Latest News

Dow Jones Newswires: Reckitt Benckiser Q3 sales rise 14% to £3.74 billion

By Anthony O. Goriainoff

Reckitt Benckiser Group PLC said Wednesday that third-quarter revenue rose as it benefitted from foreign-exchange tailwinds of 8.5%, and that continues to expect inflation on its cost of goods sold to remain in the high teens for the year.

The consumer-goods company, which houses Dettol, Harpic and Durex among its brands, said quarterly revenue rose 14% on year on a reported basis to 3.74 billion pounds ($4.29 billion). Like-for-like revenue growth was 7.4%, Reckitt said.

Year-to-date revenue stood at GBP10.6 billion.

Reckitt Benckiser said it was narrowing it full-year like-for-like net revenue growth target to a range of 6% to 8% range from the previous 5% to 8% range.

“During the second half of the year, we expect nutrition margins to normalize, a higher level of investment versus the first half of the year, and to face a tougher inflationary environment as more favorable hedge positions prevailing in the first half are renewed at higher rates,” the company said.

Write to Anthony O. Goriainoff at

What's your reaction?

In Love
Not Sure

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Latest News